Corwin v. British Am. Tobacco, Plc

2015 NCBC 3
CourtNorth Carolina Business Court
DecidedJanuary 8, 2015
Docket14-CVS-8130
StatusPublished

This text of 2015 NCBC 3 (Corwin v. British Am. Tobacco, Plc) is published on Counsel Stack Legal Research, covering North Carolina Business Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Corwin v. British Am. Tobacco, Plc, 2015 NCBC 3 (N.C. Super. Ct. 2015).

Opinion

Corwin v. British Am. Tobacco, PLC, 2015 NCBC 3.

STATE OF NORTH CAROLINA IN THE GENERAL COURT OF JUSTICE SUPERIOR COURT DIVISION COUNTY OF GUILFORD 14 CVS 8130

DR. ROBERT CORWIN AS TRUSTEE ) FOR THE BEATRICE CORWIN ) LIVING IRREVOCABLE TRUST, on ) Behalf of a Class of Those Similarly ) Situated, ) ) Plaintiff, ) ) v. ) ) BRITISH AMERICAN TOBACCO ) PLC; REYNOLDS AMERICAN, INC.; ) INTERIM ORDER ON DEFENDANTS’ SUSAN M. CAMERON; JOHN P. ) MOTIONS TO STAY DISCOVERY DALY; NEIL R. WITHINGTON; ) LUC JOBIN; SIR NICHOLAS ) SCHEELE; MARTIN D. FEINSTEIN; ) RONALD S. ROLFE; RICHARD E. ) THORNBURGH; HOLLY K. ) KOEPPEL; NANA MENSAH; ) LIONEL L. NOWELL III; JOHN J. ) ZILLMER; and THOMAS C. ) WAJNERT, ) ) Defendants. ) )

{1} THIS MATTER is before the Court on Defendants Reynolds American Inc., (“RAI”) Cameron, Daly, Feinstein, Rolfe, Withington, Scheele, Jobin, Thornburgh, Koeppel, Mensah, Nowell, Zillmer, and Wajnert’s (“the Director Defendants;” together with RAI, “the RAI Defendants”) Motion to Stay Discovery (“RAI and Directors’ Motion”) and British American Tobacco p.l.c’s (“BAT”) Motion to Stay Discovery and for Protective Order (“BAT’s Motion;” collectively “the Motions”). These Motions seek to stay all discovery pending the Court’s determination of motions to dismiss the complaint. After the Motions were filed, RAI scheduled a shareholders’ meeting on January 28, 2015. In response, Plaintiff filed a Motion for Preliminary Injunction that seeks to enjoin that shareholders’ meeting until further disclosures are made, and seeks a more narrow set of discovery on an expedited basis regarding three defined subject matters for which he contends disclosures made to date are inadequate. For reasons expressed below, the Court concludes that no expedited discovery is required from BAT prior to the hearing on Plaintiffs Motion for Preliminary Injunction on January 16, 2015, that RAI should produce limited discovery on an expedited basis, and that the Court otherwise defers a final ruling on the motions to stay discovery. {2} Any findings of fact and conclusions of law in this Order are solely for purposes of determining the Motions and are not intended to become the law of the case.

I. OVERVIEW OF MATTER PRESENTED

{3} The litigation involves a transaction announced on July 15, 2014, involving RAI, BAT, Lorillard, Inc. (“Lorillard”), and Imperial Tobacco Group p.l.c. (“Imperial”) (the “Transaction”). Plaintiff asserts a number of claims and, for convenience, refers to some as “fairness claims” and some as “disclosure claims.” This Order is limited to disclosure claims, and more particularly to discovery related to Plaintiff’s Motion for Preliminary Injunction to Enjoin Shareholder Meeting and Vote. The Court expresses no opinion as to any other discovery. {4} Lazard Frères & Co, LLC (“Lazard”) served as the RAI’s financial advisor in connection with the Transaction. {5} Under this transaction, RAI would acquire Lorillard by paying Lorillard shareholders a combination of cash and RAI shares, Lorillard would sell certain brands to Imperial, and BAT would purchase additional shares to allow BAT to maintain its current 42% ownership stake in RAI. To complete the Transaction, RAI shareholders must approve the issuance of the shares necessary for the sale to BAT. That is the purpose of the January 28 shareholders’ meeting. {6} The transactional documents set a reference price of $60.16 for RAI shares. BAT will purchase its shares at that price. Lorillard shareholders will receive cash and a fixed amount of shares, so that the total value of the transaction to a Lorillard shareholder varies as the market price fluctuates until the date of closing. As of the date of this Order, the value of one share of RAI is above $60.16. {7} While Plaintiff will ultimately pursue broader discovery, he seeks at this time to have expedited discovery in three areas necessary to fully present his preliminary injunction motion. The areas relate to a possible technology sharing agreement, details regarding Lazard’s discounted cash flow (“DCF”) analysis, and matters related to potential regulation of menthol products. {8} When announcing the Transaction on July 15, 2014, both RAI and BAT referenced, among other things, that RAI and BAT had agreed to pursue a technology sharing agreement. Certain members of the investment community apparently concluded from the wording of the press releases and subsequent statements by RAI and BAT management that a technology sharing agreement had, in fact, been reached. RAI management later stated during earnings calls that such an agreement had not yet been reached. RAI’s CFO and lead negotiator, Thomas R. Adams, has now submitted an affidavit that no technology sharing agreement has been reached. (Adams Aff. ¶ 9.) He does not otherwise discuss any agreement in principle to pursue such an agreement. {9} The Joint Proxy/Prospectus that RAI and Lorillard jointly filed on December 22, 2014, refers to a technology sharing agreement only when describing this litigation. RAI asserts that the terms of various transactions necessary to consummate the overall Transaction reflect that they are not conditioned on any technology sharing agreement being finalized. {10} Plaintiff seeks expedited discovery regarding the basis and background of public statements made by RAI and BAT regarding a technology sharing agreement. Defendants resist. {11} RAI has agreed to produce, subject to a protective order, further information regarding Lazard’s DCF analysis. The Court finds that this production is adequate at this time as to this subject. The Court will approve an appropriate protective order when presented. {12} As to discovery regarding matters related to potential regulation of menthol, the Court finds that Plaintiff has not made an adequate showing to justify expedited discovery.

II. PROCEDURAL HISTORY

{13} Plaintiff filed his Class Action Complaint on August 8, 2014, subsequently filing his First Amended Class Action Complaint on November 7, 2014, asserting claims based on breaches of fiduciary duties of care, loyalty, and candor, and asserting that BAT owes fiduciary duties to RAI shareholders as a controlling shareholder, even though it owns a minority interest in RAI. {14} Defendants moved to dismiss the First Amended Class Action Complaint, with the RAI Defendants alleging that Plaintiff has no standing to bring a claim against them and BAT claiming that it owes no fiduciary duties to RAI shareholders. Defendants also moved to stay all discovery pending ruling on the motions to dismiss. BAT filed its Motion to Stay Discovery and for Protective Order on December 5, 2014. The RAI Defendants filed their Motion to Stay Discovery on December 8, 2014. Plaintiff filed its Omnibus Opposition to Defendants’ Motions to Stay Discovery on December 17, 2014. The RAI Defendants and BAT filed their replies on December 29, 2014. {15} On December 22, 2014, RAI announced that a shareholder vote would be held on January 28, 2015, to approve the share issuance related to the subscription agreement between RAI and BAT. Plaintiff indicated that it wished to pursue a narrowed area of discovery limited to its disclosure claims on an expedited basis. During a conference with the parties on December 30, 2015, the Court allowed supplemental briefing on the Motions. Plaintiff filed his Motion for Preliminary Injunction to Enjoin Shareholder Meeting and Vote. RAI Defendants filed their supplemental brief on January 5, 2015, and Plaintiff filed on January 6, 2015. Defendants filed Adams’s affidavit in conjunction with their supplemental filing. BAT filed no supplemental brief, standing on its position that no discovery should be required of it until a ruling on the motions to dismiss, as any discovery the court might deem necessary on the disclosure claims could be adequately made by the RAI Defendants.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Cogent, Inc. Shareholder Litigation
7 A.3d 487 (Court of Chancery of Delaware, 2010)
Ehrenhaus v. Baker
717 S.E.2d 9 (Court of Appeals of North Carolina, 2011)
Dimension Data North America, Inc. v. Netstar-1, Inc.
226 F.R.D. 528 (E.D. North Carolina, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
2015 NCBC 3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/corwin-v-british-am-tobacco-plc-ncbizct-2015.